JP2006505533A5 - - Google Patents

Download PDF

Info

Publication number
JP2006505533A5
JP2006505533A5 JP2004537065A JP2004537065A JP2006505533A5 JP 2006505533 A5 JP2006505533 A5 JP 2006505533A5 JP 2004537065 A JP2004537065 A JP 2004537065A JP 2004537065 A JP2004537065 A JP 2004537065A JP 2006505533 A5 JP2006505533 A5 JP 2006505533A5
Authority
JP
Japan
Prior art keywords
pyrrolidin
urea
methyl
quinolin
diphenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
JP2004537065A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006505533A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2003/010154 external-priority patent/WO2004026836A2/en
Publication of JP2006505533A publication Critical patent/JP2006505533A/ja
Publication of JP2006505533A5 publication Critical patent/JP2006505533A5/ja
Abandoned legal-status Critical Current

Links

JP2004537065A 2002-09-17 2003-09-12 1−ピリジン−4−イル−尿素誘導体 Abandoned JP2006505533A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP0210417 2002-09-17
PCT/EP2003/010154 WO2004026836A2 (en) 2002-09-17 2003-09-12 1-pyridin-4-yl-urea derivatives

Publications (2)

Publication Number Publication Date
JP2006505533A JP2006505533A (ja) 2006-02-16
JP2006505533A5 true JP2006505533A5 (https=) 2006-10-19

Family

ID=32010909

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004537065A Abandoned JP2006505533A (ja) 2002-09-17 2003-09-12 1−ピリジン−4−イル−尿素誘導体

Country Status (13)

Country Link
US (1) US20060094716A1 (https=)
EP (1) EP1554249A2 (https=)
JP (1) JP2006505533A (https=)
KR (1) KR20050043967A (https=)
CN (1) CN1681789A (https=)
AU (1) AU2003270186A1 (https=)
BR (1) BR0314353A (https=)
CA (1) CA2496624A1 (https=)
MX (1) MXPA05002839A (https=)
NO (1) NO20050932L (https=)
RU (1) RU2005111589A (https=)
WO (1) WO2004026836A2 (https=)
ZA (1) ZA200502009B (https=)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA05005660A (es) 2002-11-27 2005-10-18 Incyte Corp Derivados de 3-aminopirrolidina como moduladores de receptores de quimocina.
US7288538B2 (en) 2003-02-20 2007-10-30 Encysive Pharmaceuticals, Inc. Phenylenediamine urotensin-II receptor antagonists and CCR-9 antagonists
US7319111B2 (en) 2003-02-20 2008-01-15 Encysive Pharmaceuticals, Inc. Phenylenediamine Urotensin-II receptor antagonists and CCR-9 antagonists
EP1603884A4 (en) 2003-02-28 2008-05-28 Encysive Pharmaceuticals Inc PYRIDINE, PYRIMIDINE, QUINOLINE, QUINAZOLINE AND NAPHTHALENE UROTENSIN II RECEPTOR ANTAGONISTS
US7320989B2 (en) 2003-02-28 2008-01-22 Encysive Pharmaceuticals, Inc. Pyridine, pyrimidine, quinoline, quinazoline, and naphthalene urotensin-II receptor antagonists
WO2004078749A1 (en) 2003-03-06 2004-09-16 Glaxo Group Limited Heterocyclic urea derivatives for the treatment of pain
US7514562B2 (en) * 2003-03-07 2009-04-07 Glaxo Group Limited Urea derivatives and their use as vanilloid receptor antagonists in the treatment of pain
GB0305426D0 (en) 2003-03-08 2003-04-16 Glaxo Group Ltd Novel compounds
CA2520763A1 (en) 2003-04-03 2004-10-21 The Regents Of The University Of California Improved inhibitors for the soluble epoxide hydrolase
US7750161B2 (en) * 2003-09-26 2010-07-06 Daniel Bur Pyridine derivatives
EP1765311A4 (en) 2004-03-16 2009-04-29 Univ California REDUCTION OF NEPHROPATHY WITH INHIBITORS OF SOLUBLE EPOXY HYDROLASE AND EPOXYEICOSANOIDS
MX2007004293A (es) * 2004-10-12 2007-06-18 Actelion Pharmaceuticals Ltd 1[2-(4-bencil-4-hidroxi-piperidin-1-il)-etil]-3-(2-metil-quinolin -4-il)-urea como la sal de sulfato cristalina.
US7662910B2 (en) 2004-10-20 2010-02-16 The Regents Of The University Of California Inhibitors for the soluble epoxide hydrolase
WO2007034325A1 (en) 2005-09-21 2007-03-29 Pfizer Limited Carboxamide derivatives as muscarinic receptor antagonists
AR059826A1 (es) * 2006-03-13 2008-04-30 Univ California Inhibidores de urea conformacionalmente restringidos de epoxido hidrolasa soluble
WO2008144268A1 (en) * 2007-05-15 2008-11-27 Boehringer Ingelheim International Gmbh Urotensin ii receptor antagonists
MX2010012855A (es) * 2008-06-03 2010-12-21 Actelion Pharmaceuticals Ltd Derivados de [4-(1-amino-etil)-ciclohexil]-metil-amina y [6-(1-amino-etil)-tetrahidro-piran-3-il]-metil-amina como antibacterianos.
EP2528604B1 (en) 2010-01-29 2017-11-22 The Regents of the University of California Acyl piperidine inhibitors of soluble epoxide hydrolase
BR112012024705A2 (pt) * 2010-03-31 2016-06-07 Actelion Pharmaceuticals Ltd derivados antibacterianos de isoquinolin-3-ilureia
MX344772B (es) * 2011-01-28 2017-01-06 Univ Kentucky Res Found Analogos de estilbeno y metodos para tratar cancer.
CA2974784A1 (en) 2015-01-23 2016-07-28 Gvk Biosciences Private Limited Inhibitors of trka kinase
CN107056673B (zh) * 2016-09-09 2019-10-29 南京工业大学 一种3,4-二芳基马来酰亚胺衍生物及其制备方法与应用
CN106432039B (zh) * 2016-09-27 2019-02-22 南京工业大学 3,4-二芳基马来酰亚胺衍生物及其制备方法与应用
CN110862398B (zh) * 2018-08-27 2021-04-06 北京赛特明强医药科技有限公司 脲取代的芳环连二噁烷并喹唑啉或喹啉类化合物、组合物及其应用
CN119841865A (zh) 2020-02-07 2025-04-18 加舒布鲁姆生物公司 杂环glp-1激动剂
EP4211139A4 (en) 2020-09-10 2024-12-18 Gasherbrum Bio, Inc. HETEROCYCLIC GLP-1 AGONISTS
AU2024222719A1 (en) 2023-02-16 2025-08-21 Gasherbrum Bio, Inc. Heterocyclic glp-1 agonists
CN119219821A (zh) * 2024-12-03 2024-12-31 江苏金杉新材料有限公司 用于湿法冶金的苯乙烯系阴离子树脂及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR016817A1 (es) * 1997-08-14 2001-08-01 Smithkline Beecham Plc Derivados de fenilurea o feniltiourea, procedimiento para su preparacion, coleccion de compuestos, compuestos intermediarios, composicion farmaceutica,metodo de tratamiento y uso de dichos compuestos para la manufactura de un medicamento
AUPP003197A0 (en) * 1997-09-03 1997-11-20 Fujisawa Pharmaceutical Co., Ltd. New heterocyclic compounds
AU2804400A (en) * 1999-02-12 2000-08-29 Smithkline Beecham Plc Phenyl urea and phenyl thiourea derivatives as orexin receptor antagonists
NZ527276A (en) * 2001-03-27 2004-11-26 Actelion Pharmaceuticals Ltd 1,2,3,4-tetrahydroisoquinoline derivatives as urotensin II receptor antagonists
WO2003048154A1 (en) * 2001-12-04 2003-06-12 Actelion Pharmaceuticals Ltd 4-(piperidyl- and pyrrolidyl-alkyl-ureido) -quinolines as urotensin ii receptor antagonists

Similar Documents

Publication Publication Date Title
JP2006505533A5 (https=)
RU2005111589A (ru) Производные 1-пиридин-4-илмочевины
EP1960370B1 (de) Pyridiazinonderivate zur behandlung von tumoren
CA2473892A1 (en) Novel quinoline derivatives
EP2150539B1 (de) Pyridazinonderivate
US9452997B2 (en) Piperidine and piperazine derivatives as autotaxin inhibitors
US8680139B2 (en) Anti-neoplastic compounds, compositions and methods
EP2220070B1 (de) 2-benzylpyridazinonderivate als met-kinasehemmer
US8637518B2 (en) Pyridazinone derivatives
US9815832B2 (en) Azabenzimidazole compounds
EP2152370B1 (de) Arylether-pyridazinonderivate
EP2513057B1 (de) Inhibitoren der sphingosinkinase
JP2004529132A5 (https=)
TW200403058A (en) Heterocyclo inhibitors of potassium channel function
EP2049531A2 (de) 2-(heterocyclylbenzyl)-pyridazinonderivate
DE102007032507A1 (de) Pyridazinonderivate
DE102007038957A1 (de) 6-Thioxo-pyridazinderivate
DK2621916T3 (en) Benzazole derivatives as histamine H 4 receptor ligands
KR20050059164A (ko) 치환된 1,4-디-피페리딘-4-일-피페라진 유도체 및 뉴로키닌길항제로서의 그의 용도
JP2011505388A (ja) レニン阻害剤
WO2009152920A1 (de) 3-(3-pyrimidin-2-yl-benzyl)-[1,2,4]triazolo[4,3-b]pyridazin-derivative als met-kinase inhibitoren
JP2007506692A5 (https=)
RU2006113948A (ru) Производные пиридина и их применение в качестве антагонистов уротензина ii
EP2958901B1 (de) 2-amino-3,4-dihydro-chinazolin derivate und ihre verwendung als cathepsin d inhibitoren
EP0727421B1 (en) Agents for improving sleep